SFE - Safeguard Scientifics, Inc.

NYSE - NYSE Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
0
0
0
0
0
Cost of Revenue
-
-
-
-
0
Gross Profit
-
-
-
-
0
Operating Expenses
Research Development
-
-
-
-
-
Selling General and Administrative
10,540
16,871
17,131
18,692
17,554
Total Operating Expenses
10,540
16,871
17,131
18,692
17,554
Operating Income or Loss
-10,540
-16,871
-17,131
-18,692
-17,554
Interest Expense
20,668
16,067
8,620
4,634
4,523
Total Other Income/Expenses Net
67,350
14,503
-66,697
-1,011
-39,382
Income Before Tax
38,636
-15,629
-88,572
-22,262
-59,524
Income Tax Expense
0
0
0
0
0
Income from Continuing Operations
38,636
-15,629
-88,572
-22,262
-59,524
Net Income
38,636
-15,629
-88,572
-22,262
-59,524
Net Income available to common shareholders
38,636
-15,629
-88,572
-22,262
-59,524
Reported EPS
Basic
-
-0.76
-4.34
-1.09
-2.85
Diluted
-
-0.76
-4.34
-1.09
-2.85
Weighted average shares outstanding
Basic
-
20,544
20,430
20,343
20,874
Diluted
-
20,544
20,430
20,343
20,874
EBITDA
-
1,130
-79,630
-17,300
-54,811